Insulin resistance serves as a central mediator in this process, promoting adipose tissue lipolysis, impairing very low-density lipoprotein secretion, and activating lipogenic transcription factors such as SREBP-1c in hepatocytes (40). Here, SREBF1 is linked to Insulin resistance.